| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.10▼ | 1.09▼ | 1.08▲ | 1.08▲ | 1.08▲ |
| MA10 | 1.09▲ | 1.08▲ | 1.08▲ | 1.07▲ | 1.10▼ |
| MA20 | 1.08▲ | 1.08▲ | 1.08▲ | 1.07▲ | 1.20▼ |
| MA50 | 1.07▲ | 1.08▲ | 1.08▲ | 1.12▼ | 1.19▼ |
| MA100 | 1.09▲ | 1.10▼ | 1.10▼ | 1.21▼ | 5.52▼ |
| MA200 | 1.10▼ | 1.13▼ | 1.16▼ | 1.21▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.003▲ | 0.003▲ | 0.007▲ | 0.018▲ |
| RSI | 53.461▲ | 54.098▲ | 53.523▲ | 50.278▲ | 40.053▼ |
| STOCH | 88.889▲ | 80.000▲ | 73.333 | 43.333 | 24.607 |
| WILL %R | -20.000▲ | -20.000▲ | -20.000▲ | -33.333 | -74.619 |
| CCI | 35.498 | 91.057 | 96.124 | 194.204▲ | -70.839 |
|
Thursday, June 19, 2025 05:01 PM
MENLO PARK, Calif., May 29, 2025--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron ...
|
|
Thursday, June 19, 2025 05:01 PM
Explore AN2 Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ANTX.
|
|
Sunday, June 01, 2025 05:00 PM
Eric Easom, the Chief Executive Officer of $ANTX, bought 10,000 shares of the company on 06-02-2025 for an estimated $10,665.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/07/25 | 1.095 | 1.10 | 1.09 | 1.09 | 48,035 |
| 17/07/25 | 1.08 | 1.10 | 1.075 | 1.09 | 59,765 |
| 16/07/25 | 1.06 | 1.09 | 1.06 | 1.08 | 27,300 |
| 15/07/25 | 1.08 | 1.10 | 1.05 | 1.05 | 131,112 |
| 14/07/25 | 1.06 | 1.08 | 1.0547 | 1.07 | 57,167 |
| 11/07/25 | 1.07 | 1.08 | 1.0518 | 1.06 | 28,499 |
| 10/07/25 | 1.07 | 1.085 | 1.07 | 1.07 | 27,735 |
| 09/07/25 | 1.05 | 1.09 | 1.05 | 1.07 | 80,033 |
| 08/07/25 | 1.05 | 1.09 | 1.05 | 1.06 | 109,200 |
| 07/07/25 | 1.0968 | 1.0999 | 1.05 | 1.05 | 69,399 |
|
|
||||
|
|
||||
|
|